"Biomaterials-based cancer immunotherapy"
Immunotherapy has achieved significant clinical success in the past few years, but there remains tremendous room for the development of new-generation therapies with more robust and persistent immune responses. In this talk, I will introduce how macroporous biomaterials can recruit and modulate immune cells in situ to regulate systemic immune responses, for the development of immunotherapies. Two main examples will be given, one focused on developing a technology to manipulate immune cell interactions and the other aimed at developing a generalizable therapy for hard-to-treat solid tumors.
